Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates
DRRXDURECT (DRRX) Zacks Investment Research·2024-05-14 06:21

Durect (DRRX) came out with a quarterly loss of 0.25pershareversustheZacksConsensusEstimateofalossof0.25 per share versus the Zacks Consensus Estimate of a loss of 0.21. This compares to loss of 0.52pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−19.050.52 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -19.05%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of 0.36 per share when it actually produced a loss of $0.27, delivering a surprise of 25%. Over the last four quarters, the comp ...